Tar Heel Times
Your comprehensive source for Tar Heel sports news

UNC ranked 7th among biomedical research institutions

Researchers at the University of North Carolina at Chapel Hill are using genetically engineered mouse models to help predict how humans will respond to different chemotherapy drug combinations used to fight breast cancer. Last year, UNC scientists identified biomarkers for challenging molecular subtypes of human breast cancer in genetically engineered mice, specifically looking for types that have few known targets and available therapies. (Fierce Biotech Research)

Share: Facebook | Twitter | Email


Recent Campus Connections News:

Dr. Aziz Sancar was awarded a key to the town of Chapel Hill

Orange County receives grant to help dementia patients like Dean Smith

Top of the Hill named one of 'Top 10 brewpubs in the U.S.'

Mipso, string band that formed at UNC, tied to North Carolina by family, past and music

Master bell ringer plays Morehead’s tunes

© 2005-2015 Tar Heel Times | Contact | Privacy Policy | Site Map | RSS | Did UNC Win?

Tar Heel Times is an unofficial resource for UNC fans and is not affiliated with the University of North Carolina.